Clinical Trial Update: A Pilot Study of Total-body PET Using FDA-approved Radiotracers Beyond 18F-FDG

View source ↗

Summary

A pilot study evaluating total-body PET imaging with FDA-approved radiotracers beyond 18F-FDG to image cancer. It aims to assess feasibility and potential diagn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Neuroendocrine Tumor
• Prostate Cancer

Snippet

Sponsor: University of California, Davis | Conditions: Prostate Cancer, Breast Cancer | Status: ENROLLING_BY_INVITATION